Suchergebnisse - "Hauser, Stefan"

PubPharm (6)

1

Clinical implications of AGR2 in primary prostate cancer : Results from a large-scale study

enthalten in: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica | 2024

von Wambach, M. | Montani, M. | Runz, J. | +12

2

The value of tumor markers in men with metastatic prostate cancer undergoing [177 Lu]Lu-PSMA therapy

enthalten in: The Prostate | 2020

von Yordanova, A. | Linden, P. | Hauser, S. | +6

3

Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [177Lu]Lu-PSMA-617 radioligand therapy

enthalten in: Oncotarget | 2017

von Ahmadzadehfar, H. | Schlolaut, S. | Fimmers, R. | +7

4

Radioligand therapy of metastatic prostate cancer using 177Lu-PSMA-617 after radiation exposure to 223Ra-dichloride

enthalten in: Oncotarget | 2017

von Ahmadzadehfar, H. | Zimbelmann, S. | Yordanova, A. | +7

5

68Ga-PSMA-11 PET as a Gatekeeper for the Treatment of Metastatic Prostate Cancer with 223Ra : Proof of Concept

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2017

von Ahmadzadehfar, H. | Azgomi, K. | Hauser, S. | +6

6

Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with 177Lu-PSMA-617

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2017

von Ferdinandus, J. | Eppard, E. | Gaertner, F. | +7

1
[1]